RNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid Proteins

An engineered RNase P-based ribozyme variant, which was generated using the in vitro selection procedure, was used to target the overlapping mRNA region of two proteins essential for human cytomegalovirus (HCMV) replication: capsid assembly protein (AP) and protease (PR). In vitro studies showed tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhu, Reeves, Michael, Ye, Jun, Trang, Phong, Zhu, Li, Sheng, Jingxue, Wang, Yu, Zen, Ke, Wu, Jianguo, Liu, Fenyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517104/
https://www.ncbi.nlm.nih.gov/pubmed/26114473
http://dx.doi.org/10.3390/v7072775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517104/
https://www.ncbi.nlm.nih.gov/pubmed/26114473
http://dx.doi.org/10.3390/v7072775

Ejemplares similares